Biocardia announces us patent on imaging system for targeting cardiac therapies

Sunnyvale, calif., june 15, 2022 (globe newswire) -- biocardia®, inc. [nasdaq: bcda], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces that the united states patent office has granted patent number 11,357,463: titled, “target site selection, entry and update with automatic remote image annotation”, with a patent term that will expire in late 2034.
BCDA Ratings Summary
BCDA Quant Ranking